Leerink Partnrs Has Bullish Forecast for UHS Q4 Earnings

Universal Health Services, Inc. (NYSE:UHS) – Equities research analysts at Leerink Partnrs boosted their Q4 2025 earnings estimates for shares of Universal Health Services in a research report issued on Wednesday, October 22nd. Leerink Partnrs analyst W. Mayo now anticipates that the health services provider will post earnings of $6.17 per share for the quarter, up from their previous forecast of $5.97. The consensus estimate for Universal Health Services’ current full-year earnings is $15.92 per share. Leerink Partnrs also issued estimates for Universal Health Services’ Q2 2026 earnings at $5.93 EPS and Q4 2026 earnings at $6.58 EPS.

Universal Health Services (NYSE:UHS) last issued its earnings results on Monday, July 28th. The health services provider reported $5.35 EPS for the quarter, beating analysts’ consensus estimates of $4.85 by $0.50. The firm had revenue of $4.28 billion for the quarter, compared to the consensus estimate of $4.24 billion. Universal Health Services had a return on equity of 18.25% and a net margin of 7.66%.The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.31 earnings per share. Universal Health Services has set its FY 2025 guidance at 20.000-21.000 EPS.

Several other analysts also recently commented on UHS. Wall Street Zen raised shares of Universal Health Services from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 11th. Royal Bank Of Canada upped their price target on Universal Health Services from $201.00 to $206.00 and gave the stock a “sector perform” rating in a research note on Tuesday, August 19th. Wells Fargo & Company boosted their price objective on shares of Universal Health Services from $210.00 to $249.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Barclays dropped their target price on shares of Universal Health Services from $259.00 to $250.00 and set an “overweight” rating on the stock in a report on Thursday, September 18th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Universal Health Services in a report on Wednesday, October 8th. Four investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $218.69.

Universal Health Services Trading Up 1.6%

Shares of NYSE UHS opened at $210.08 on Thursday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.19 and a current ratio of 1.29. The stock has a market cap of $13.37 billion, a price-to-earnings ratio of 11.06, a PEG ratio of 0.85 and a beta of 1.30. Universal Health Services has a 52 week low of $152.33 and a 52 week high of $235.16. The business has a 50 day simple moving average of $193.05 and a 200 day simple moving average of $182.88.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Zions Bancorporation National Association UT bought a new position in Universal Health Services in the first quarter worth $30,000. CYBER HORNET ETFs LLC bought a new position in shares of Universal Health Services during the 2nd quarter worth about $29,000. MUFG Securities EMEA plc bought a new position in shares of Universal Health Services during the 2nd quarter worth about $31,000. First Horizon Advisors Inc. lifted its stake in Universal Health Services by 347.6% during the second quarter. First Horizon Advisors Inc. now owns 188 shares of the health services provider’s stock worth $34,000 after purchasing an additional 146 shares during the period. Finally, Mather Group LLC. bought a new position in Universal Health Services during the third quarter worth about $40,000. 86.05% of the stock is owned by institutional investors.

Universal Health Services Company Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.